Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pritchard

Showing results (221-230 of 260) with videos related to

Pageof 26
Sort By:
British Journal of Cancer|March 16, 2013
Peptide receptor radionuclide therapy with (90)Y-DOTATATE/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicityS Vinjamuri, T M Gilbert, M Banks, et al.
Cancer Letters|May 27, 2019
RETRACTED: IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomasK Mihajluk, C Simms, M Reay, et al.
Cancer Letters|March 20, 2021
Retraction notice to " IP1867B suppresses the Insulin-like Growth Factor 1 Receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas" [Canc. Lett., 458 (2019) pages 29-38]K Mihajluk, C Simms, M Reay, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 18, 2000
Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockadeM M Hagan, P A Rushing, L M Pritchard, et al.
Gut|November 26, 2011
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel diseaseR Kiesslich, C A Duckworth, D Moussata, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement|March 5, 2019
The Short Performance Physical Battery Is Associated with One-Year Emergency Department Visits and HospitalizationAhmed M Negm, Courtney C Kennedy, Janet M Pritchard, et al.
Pharmaceutical Research|June 8, 2014
Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastomaEleanor M Pritchard, Elizabeth Stewart, Fangyi Zhu, et al.
Journal of Aging Research|February 19, 2015
The Relationship between Intramuscular Adipose Tissue, Functional Mobility, and Strength in Postmenopausal Women with and without Type 2 DiabetesJanet M Pritchard, Sarah Karampatos, Karen A Beattie, et al.
Leukemia|August 23, 2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk, S C Raimondi, D K Srivastava, et al.
Organic & Biomolecular Chemistry|May 27, 2016
Synthesis and determination of absolute configuration of a non-peptidic αvβ6 integrin antagonist for the treatment of idiopathic pulmonary fibrosisNiall A Anderson, Ian B Campbell, Brendan J Fallon, et al.
Pageof 26

Showing results (221-230 of 260) with videos related to

Sort By:
Pageof 26
British Journal of Cancer|March 16, 2013
Peptide receptor radionuclide therapy with (90)Y-DOTATATE/(90)Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicityS Vinjamuri, T M Gilbert, M Banks, et al.
Cancer Letters|May 27, 2019
RETRACTED: IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomasK Mihajluk, C Simms, M Reay, et al.
Cancer Letters|March 20, 2021
Retraction notice to " IP1867B suppresses the Insulin-like Growth Factor 1 Receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas" [Canc. Lett., 458 (2019) pages 29-38]K Mihajluk, C Simms, M Reay, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 18, 2000
Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockadeM M Hagan, P A Rushing, L M Pritchard, et al.
Gut|November 26, 2011
Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel diseaseR Kiesslich, C A Duckworth, D Moussata, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement|March 5, 2019
The Short Performance Physical Battery Is Associated with One-Year Emergency Department Visits and HospitalizationAhmed M Negm, Courtney C Kennedy, Janet M Pritchard, et al.
Pharmaceutical Research|June 8, 2014
Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastomaEleanor M Pritchard, Elizabeth Stewart, Fangyi Zhu, et al.
Journal of Aging Research|February 19, 2015
The Relationship between Intramuscular Adipose Tissue, Functional Mobility, and Strength in Postmenopausal Women with and without Type 2 DiabetesJanet M Pritchard, Sarah Karampatos, Karen A Beattie, et al.
Leukemia|August 23, 2001
Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experienceB I Razzouk, S C Raimondi, D K Srivastava, et al.
Organic & Biomolecular Chemistry|May 27, 2016
Synthesis and determination of absolute configuration of a non-peptidic αvβ6 integrin antagonist for the treatment of idiopathic pulmonary fibrosisNiall A Anderson, Ian B Campbell, Brendan J Fallon, et al.
Pageof 26